Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Combination therapy of human bone marrow–derived mesenchymal stem cells and minocycline improves neuronal function in a rat middle cerebral artery occlusion model

Fig. 1

Rotarod test. Results of rotarod tests before middle cerebral artery occlusion (MCAO) and 1, 7, 14, 21, and 28 days after MCAO. The combination therapy group showed significant improvement compared with the control group 21 days after MCAO. At day 28, the combination group showed significant improvement compared with the control and minocycline groups. *P <0.05. Abbreviation: hBM-MSC human bone marrow–derived mesenchymal stem cell

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512